Annonacin

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Annonacin
Annonacin.png
Names
IUPAC name
(5S)-5-Methyl-3-[(2R,8R,13R)-2,8,13-trihydroxy-13- [(2R,5R)-5-[(1R)-1- hydroxytridecyl]-2-tetrahydrofuranyl] tridecyl]-5H-furan-2-one
Identifiers
3D model (JSmol)
ChemSpider
Properties
C35H64O7
Molar mass 596.89 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

Annonacin is a neurotoxic chemical compound found in some fruits such as the paw paw (custard apple), soursop, and others from the family Annonaceae. It is a member of the class of compounds known as acetogenins. Although annonacin-containing fruit products are regularly consumed throughout the West Indies for their traditional medicine uses, there is evidence linking annonacin to the development of progressive supranuclear palsy (PSP) and atypical Parkinsonism in elderly men of Guadeloupe.

Traditional medicine[edit]

Soursop fruit, a source of annonacin

Historically, plants and fruits of Annonaceae (particularly Annona muricata and Annona squamosa) have been consumed in various forms throughout the West Indies, usually as hot water extracts of leaves.[1] These annonacin-containing herbal teas serve a wide range of uses in folk medicine.[1] On the Caribbean island of Guadeloupe, such teas are consumed mainly for their sedative qualities. Use of annonacin products in Guadeloupe often lasts from early childhood through old age, and daily consumption is not uncommon.[2]

It was discovered in Guadeloupe that atypical Parkinsonism was predominant in elderly males, who regularly consume annonacin-containing herbal teas.[3] Of 87 people with Parkinsonism transferred to one clinic between 1996 and 1998, 25% had Parkinson’s, while 36% had progressive supranuclear palsy and 39% had atypical Parkinsonism.[3]

Neurotoxicity[edit]

Annonacin is a potentially lethal neurotoxin.[4][5][6] Like other acetogenins, it is a mitochondrial complex I (NADH-dehydrogenase) inhibitor.[5] As NADH-dehydrogenase is responsible for the conversion of NADH to NAD+ as well as the establishment of a proton gradient in the mitochondria, annonacin disables the ability of a cell to generate ATP through oxidative phosphorylation, leading to cell apoptosis or necrosis.[5]

The LD50 of annonacin is 0.018 μM to dopaminergic neurons, and it is the damage done to these neurons that results in the neurodegenerative effects of the toxin. Annonacin is 100 times more toxic than 1-methyl-4-phenylpyridinium (MPP+), another potent mitochondrial complex I inhibitor.[5] Compared to MPP+, annonacin produces a wider and more dramatic loss of neurons, not only in the nigro-striatal system, but in the basal ganglia and brainstem nuclei as well.[3]

Annonacin has been linked to the abnormally high incidence of progressive supranuclear palsy as well as atypical Parkinsonism in the Caribbean island of Guadeloupe where consumption of fruits such as the soursop (Annona muricata) is common.[3] An average-sized soursop fruit contains 15 mg of annonacin, while a can of commercial nectar contains 36 mg and a cup of infusion, 140 μg.[7] Studies in rodents indicates that consumption of annonacin (3.8 and 7.6 mg per kg per day for 28 days) caused brain lesions consistent with Parkinson's disease.[8][9] An adult who consumes a fruit or can of nectar daily over the course of a year is estimated to ingest the same amount of annonacin that induced brain lesions in the rodents receiving purified annonacin intravenously.[7]

Preliminary research[edit]

In vitro, annonacin is under study for its potential to affect the protein p21, cultured cancer cells,[10] and the size of tumors in nude mice.[11]

Biosynthesis[edit]

Based on basic polyketide synthesis, the biosynthesis of annonacin is likely accomplished by a modular polyketide synthase (PKS). The biosynthesis likely involves the use of 17 modules consisting of a number of enzymes commonly found in PKS. These include the acyl carrier protein (ACP), acetyl transferase (AT), ketosynthase (KS), malonyl transferase (MT; which can come carrying a variety of functionalities), ketoreductase (KR), dehydratase (DH), and enoyl reductase (ER). An example of the possible modular biosynthetic pathway detailing the combination of these enzymes and the subsequent modules can be seen in the figure below.

Depiction of the modular polyketide synthesis of annonacin

References[edit]

  1. ^ a b Ross, I. A. (2003). Annona muricata L. Medicinal Plants of the World, Vol. 1: Chemical Constituents, Traditional and Modern Medicinal Uses,1, 133-142. doi:10.1385/1-59259-365-8:133
  2. ^ Lannuzel, A. and Michel, P. P. (2008). Atypical Parkinsonism in the French West Indies: The Plant Toxin Annonacin as a Potential Etiological Factor. Cortico-Subcortical Dynamics in Parkinson¿s Disease, 1-8. doi:10.1007/978-1-60327-252-0_18
  3. ^ a b c d Caparros-Lefebvre, D., & Elbaz, A. (1999). Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. The Lancet, 354(9175), 281-286. doi:10.1016/s0140-6736(98)10166-6
  4. ^ Levine, R. A.; Richards, K. M.; Tran, K; Luo, R; Thomas, A. L.; Smith, R. E. (2015). "Determination of Neurotoxic Acetogenins in Pawpaw (Asimina triloba) Fruit by LC-HRMS". Journal of Agricultural and Food Chemistry. 63 (4): 1053. PMID 25594104. doi:10.1021/jf504500g. 
  5. ^ a b c d Potts, L. F.; Luzzio, F. A.; Smith, S. C.; Hetman, M; Champy, P; Litvan, I (2012). "Annonacin in Asimina triloba fruit: Implication for neurotoxicity". NeuroToxicology. 33 (1): 53–8. PMID 22130466. doi:10.1016/j.neuro.2011.10.009. 
  6. ^ Le Ven, J.; Schmitz-Afonso, I.; Touboul, D.; Buisson, D.; Akagah, B.; Cresteil, T.; Lewin, G.; Champy, P. (2011). "Annonaceae fruits and parkinsonism risk: Metabolisation study of annonacin, a model neurotoxin; evaluation of human exposure". Toxicology Letters. 205: S50. doi:10.1016/j.toxlet.2011.05.197. 
  7. ^ a b Champy, P; Melot, A; Guérineau Eng, V; Gleye, C; Fall, D; Höglinger, G. U.; Ruberg, M; Lannuzel, A; Laprévote, O; Laurens, A; Hocquemiller, R (2005). "Quantification of acetogenins in Annona muricata linked to atypical Parkinsonism in Guadeloupe". Movement Disorders. 20 (12): 1629–33. PMID 16078200. doi:10.1002/mds.20632. 
  8. ^ Lannuzel, A.; Michel, P. P.; Höglinger, G. U.; Champy, P.; Jousset, A.; Medja, F.; Lombès, A.; Darios, F.; et al. (2003). "The Mitochondrial Complex I Inhibitor Annonacin is Toxic to Mesencephalic Dopaminergic Neurons by Impairment of Energy Metabolism". Neuroscience. 121 (2): 287–296. PMID 14521988. doi:10.1016/S0306-4522(03)00441-X. 
  9. ^ Champy, P.; Höglinger, G. U.; Féger, J.; Gleye, C.; Hocquemiller, R.; Laurens, A.; Guérineau, V.; Laprévote, O.; et al. (2003). "Annonacin, a Lipophilic Inhibitor of Mitochondrial Complex I, induces Nigral and Striatal Neurodegeneration in Rats: Possible Relevance for Atypical Parkinsonism in Guadeloupe". Journal of Neurochemistry. 88 (1): 63–69. PMID 14675150. doi:10.1046/j.1471-4159.2003.02138.x. 
  10. ^ Yuan, S. S.; Chang, H. L.; Chen, H. W.; Yeh, Y. T.; Kao, Y. H.; Lin, K. H.; Wu, Y. C.; Su, J. H. (2003). "Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase-3-related pathway". Life sciences. 72 (25): 2853–61. PMID 12697268. 
  11. ^ Tundis, R; Xiao, J; Loizzo, M. R. (2017). "Annona species (Annonaceae): A rich source of potential antitumor agents?". Annals of the New York Academy of Sciences. PMID 28415154. doi:10.1111/nyas.13339. 

External links[edit]